Literature DB >> 19913970

[Organizing pneumonia associated with the use of trastuzumab].

Alvaro Taus-García1, Albert Sánchez-Font, Sònia Servitja-Tormo, Lara Pijuan, José María Maiques-Llácer, Víctor Curull.   

Abstract

Organizing pneumonia is a clinical and histological condition in which the onset is usually subacute with respiratory symptoms and pulmonary infiltrates. It may be unknown origin (cryptogenic) or associated with other illnesses, infectious diseases or drugs. We present a 60 year-old female patient with a previous history of breast cancer, who was being treated with trastuzumab, an antiHER2 monoclonal antibody. She was diagnosed with casual pulmonary infiltrates that had histological changes compatible with organizing pneumonia. The pulmonary infiltrates disappeared on withdrawing trastuzumab treatment. Due to the increasing use of biological therapies in different medical areas, we believe it is of interest to report this pulmonary involvement attributed to the monoclonal antibody trastuzumab. Copyright 2009 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913970     DOI: 10.1016/j.arbres.2009.09.016

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  3 in total

Review 1.  Systematic review of postradiotherapy bronchiolitis obliterans organizing pneumonia in women with breast cancer.

Authors:  Gary R Epler; Eileen M Kelly
Journal:  Oncologist       Date:  2014-10-31

2.  An unusual flare of anti-synthetase syndrome during concurrent trastuzumab therapy given for recurrent breast cancer.

Authors:  Timothy D Reynolds; Vivek Mohan; Matthew Roy; Nathan Manghat; Huzaifa Adamali; Harsha Gunawardena
Journal:  Eur J Rheumatol       Date:  2017-10-25

3.  Transtuzumab induced organizing pneumonia: a case report.

Authors:  Ajay Gupta; Louise Teo; Philip Masel; David Godbolt; Geoffrey Beadle
Journal:  Springerplus       Date:  2016-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.